MedTrace Logo

A Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder

NCT01141634 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2014-03-07

No results posted yet for this study

Summary

Attention Deficit Hyperactivity Disorder (ADHD) is a developmental disorder that presents during childhood, and is characterized by developmentally inappropriate levels of inattention and/or hyperactive-impulsive behavior. It is proposed that classical homeopathic treatment can reduce the symptoms of ADHD without serious side effects. This is an open label pilot feasibility study (36 participants). Participants, age 6-16, will consult with a homeopathic practitioner who will select treatments based on classical homeopathy principles. All participants will be assessed on a 4-weekly basis for a total of 36 weeks. The purpose of the study is to assess feasibility of recruitment and patient retention, to obtain pilot data on which to base a sample size calculation for future study, and to identify major safety concerns. The study will use single homeopathic medicines approved for over-the-counter use in Canada. The primary outcome measure will be the validated Conners 3rd Edition - Parent.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

OTHER

Homeopathic Remedies

Homeopathic remedies prepared according to the standards as set out by Health Canada

Sponsors & Collaborators

  • SickKids Foundation

    collaborator OTHER

  • Centre for Addiction and Mental Health

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • University of Toronto

    lead OTHER

Principal Investigators

  • Heather S Boon, PhD · University of Toronto

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01141634 on ClinicalTrials.gov